1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Interventional Oncology Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Radiation Therapy
  • 1.2.3 Ablation
  • 1.2.4 Particle Embolization
• 1.3 Market by Application
  • 1.3.1 Global Interventional Oncology Market Share by Application: 2020 VS 2026
  • 1.3.2 Liver Cancer
  • 1.3.3 Lung Cancer
  • 1.3.4 Kidney Cancer
  • 1.3.5 Bone Cancer
  • 1.3.6 Breast Cancer
  • 1.3.7 Prostate Cancer
  • 1.3.8 Pancreatic Cancer
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Interventional Oncology Market Perspective (2015-2026)
• 2.2 Global Interventional Oncology Growth Trends by Regions
  • 2.2.1 Interventional Oncology Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Interventional Oncology Historic Market Share by Regions (2015-2020)
  • 2.2.3 Interventional Oncology Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Interventional Oncology Players by Market Size
  • 3.1.1 Global Top Interventional Oncology Players by Revenue (2015-2020)
  • 3.1.2 Global Interventional Oncology Revenue Market Share by Players (2015-2020)
• 3.2 Global Interventional Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Interventional Oncology Revenue
• 3.4 Global Interventional Oncology Market Concentration Ratio
  • 3.4.1 Global Interventional Oncology Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Interventional Oncology Revenue in 2019
• 3.5 Key Players Interventional Oncology Area Served
• 3.6 Key Players Interventional Oncology Product Solution and Service
• 3.7 Date of Enter into Interventional Oncology Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Interventional Oncology Breakdown Data by Type (2015-2026)

• 4.1 Global Interventional Oncology Historic Market Size by Type (2015-2020)
• 4.2 Global Interventional Oncology Forecasted Market Size by Type (2021-2026)

5 Interventional Oncology Breakdown Data by Application (2015-2026)

• 5.1 Global Interventional Oncology Historic Market Size by Application (2015-2020)
• 5.2 Global Interventional Oncology Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Interventional Oncology Market Size (2015-2026)
• 6.2 North America Interventional Oncology Market Size by Type (2015-2020)
• 6.3 North America Interventional Oncology Market Size by Application (2015-2020)
• 6.4 North America Interventional Oncology Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Interventional Oncology Market Size (2015-2026)
• 7.2 Europe Interventional Oncology Market Size by Type (2015-2020)
• 7.3 Europe Interventional Oncology Market Size by Application (2015-2020)
• 7.4 Europe Interventional Oncology Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Interventional Oncology Market Size (2015-2026)
• 8.2 China Interventional Oncology Market Size by Type (2015-2020)
• 8.3 China Interventional Oncology Market Size by Application (2015-2020)
• 8.4 China Interventional Oncology Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Interventional Oncology Market Size (2015-2026)
• 9.2 Japan Interventional Oncology Market Size by Type (2015-2020)
• 9.3 Japan Interventional Oncology Market Size by Application (2015-2020)
• 9.4 Japan Interventional Oncology Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Interventional Oncology Market Size (2015-2026)
• 10.2 Southeast Asia Interventional Oncology Market Size by Type (2015-2020)
• 10.3 Southeast Asia Interventional Oncology Market Size by Application (2015-2020)
• 10.4 Southeast Asia Interventional Oncology Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Boston Scientific
  • 11.1.1 Boston Scientific Company Details
  • 11.1.2 Boston Scientific Business Overview
  • 11.1.3 Boston Scientific Interventional Oncology Introduction
  • 11.1.4 Boston Scientific Revenue in Interventional Oncology Business (2015-2020))
  • 11.1.5 Boston Scientific Recent Development
• 11.2 BTG
  • 11.2.1 BTG Company Details
  • 11.2.2 BTG Business Overview
  • 11.2.3 BTG Interventional Oncology Introduction
  • 11.2.4 BTG Revenue in Interventional Oncology Business (2015-2020)
  • 11.2.5 BTG Recent Development
• 11.3 Medtronic
  • 11.3.1 Medtronic Company Details
  • 11.3.2 Medtronic Business Overview
  • 11.3.3 Medtronic Interventional Oncology Introduction
  • 11.3.4 Medtronic Revenue in Interventional Oncology Business (2015-2020)
  • 11.3.5 Medtronic Recent Development
• 11.4 Merit Medical
  • 11.4.1 Merit Medical Company Details
  • 11.4.2 Merit Medical Business Overview
  • 11.4.3 Merit Medical Interventional Oncology Introduction
  • 11.4.4 Merit Medical Revenue in Interventional Oncology Business (2015-2020)
  • 11.4.5 Merit Medical Recent Development
• 11.5 Terumo
  • 11.5.1 Terumo Company Details
  • 11.5.2 Terumo Business Overview
  • 11.5.3 Terumo Interventional Oncology Introduction
  • 11.5.4 Terumo Revenue in Interventional Oncology Business (2015-2020)
  • 11.5.5 Terumo Recent Development
• 11.6 Accuray
  • 11.6.1 Accuray Company Details
  • 11.6.2 Accuray Business Overview
  • 11.6.3 Accuray Interventional Oncology Introduction
  • 11.6.4 Accuray Revenue in Interventional Oncology Business (2015-2020)
  • 11.6.5 Accuray Recent Development
• 11.7 Alpinion Medical Systems
  • 11.7.1 Alpinion Medical Systems Company Details
  • 11.7.2 Alpinion Medical Systems Business Overview
  • 11.7.3 Alpinion Medical Systems Interventional Oncology Introduction
  • 11.7.4 Alpinion Medical Systems Revenue in Interventional Oncology Business (2015-2020)
  • 11.7.5 Alpinion Medical Systems Recent Development
• 11.8 Angiodynamics
  • 11.8.1 Angiodynamics Company Details
  • 11.8.2 Angiodynamics Business Overview
  • 11.8.3 Angiodynamics Interventional Oncology Introduction
  • 11.8.4 Angiodynamics Revenue in Interventional Oncology Business (2015-2020)
  • 11.8.5 Angiodynamics Recent Development
• 11.9 Atricure
  • 11.9.1 Atricure Company Details
  • 11.9.2 Atricure Business Overview
  • 11.9.3 Atricure Interventional Oncology Introduction
  • 11.9.4 Atricure Revenue in Interventional Oncology Business (2015-2020)
  • 11.9.5 Atricure Recent Development
• 11.10 Baylis Medical
  • 11.10.1 Baylis Medical Company Details
  • 11.10.2 Baylis Medical Business Overview
  • 11.10.3 Baylis Medical Interventional Oncology Introduction
  • 11.10.4 Baylis Medical Revenue in Interventional Oncology Business (2015-2020)
  • 11.10.5 Baylis Medical Recent Development
• 11.11 Bovie Medical
  • 10.11.1 Bovie Medical Company Details
  • 10.11.2 Bovie Medical Business Overview
  • 10.11.3 Bovie Medical Interventional Oncology Introduction
  • 10.11.4 Bovie Medical Revenue in Interventional Oncology Business (2015-2020)
  • 10.11.5 Bovie Medical Recent Development
• 11.12 Brainlab
  • 10.12.1 Brainlab Company Details
  • 10.12.2 Brainlab Business Overview
  • 10.12.3 Brainlab Interventional Oncology Introduction
  • 10.12.4 Brainlab Revenue in Interventional Oncology Business (2015-2020)
  • 10.12.5 Brainlab Recent Development
• 11.13 Bsd Medical
  • 10.13.1 Bsd Medical Company Details
  • 10.13.2 Bsd Medical Business Overview
  • 10.13.3 Bsd Medical Interventional Oncology Introduction
  • 10.13.4 Bsd Medical Revenue in Interventional Oncology Business (2015-2020)
  • 10.13.5 Bsd Medical Recent Development
• 11.14 C. R. Bard
  • 10.14.1 C. R. Bard Company Details
  • 10.14.2 C. R. Bard Business Overview
  • 10.14.3 C. R. Bard Interventional Oncology Introduction
  • 10.14.4 C. R. Bard Revenue in Interventional Oncology Business (2015-2020)
  • 10.14.5 C. R. Bard Recent Development
• 11.15 C2 Therapeutics
  • 10.15.1 C2 Therapeutics Company Details
  • 10.15.2 C2 Therapeutics Business Overview
  • 10.15.3 C2 Therapeutics Interventional Oncology Introduction
  • 10.15.4 C2 Therapeutics Revenue in Interventional Oncology Business (2015-2020)
  • 10.15.5 C2 Therapeutics Recent Development
• 11.16 Cardiofocus
  • 10.16.1 Cardiofocus Company Details
  • 10.16.2 Cardiofocus Business Overview
  • 10.16.3 Cardiofocus Interventional Oncology Introduction
  • 10.16.4 Cardiofocus Revenue in Interventional Oncology Business (2015-2020)
  • 10.16.5 Cardiofocus Recent Development
• 11.17 Cook Medical
  • 10.17.1 Cook Medical Company Details
  • 10.17.2 Cook Medical Business Overview
  • 10.17.3 Cook Medical Interventional Oncology Introduction
  • 10.17.4 Cook Medical Revenue in Interventional Oncology Business (2015-2020)
  • 10.17.5 Cook Medical Recent Development
• 11.18 Eckert And Ziegler Bebig
  • 10.18.1 Eckert And Ziegler Bebig Company Details
  • 10.18.2 Eckert And Ziegler Bebig Business Overview
  • 10.18.3 Eckert And Ziegler Bebig Interventional Oncology Introduction
  • 10.18.4 Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2015-2020)
  • 10.18.5 Eckert And Ziegler Bebig Recent Development
• 11.19 Edap Tms
  • 10.19.1 Edap Tms Company Details
  • 10.19.2 Edap Tms Business Overview
  • 10.19.3 Edap Tms Interventional Oncology Introduction
  • 10.19.4 Edap Tms Revenue in Interventional Oncology Business (2015-2020)
  • 10.19.5 Edap Tms Recent Development
• 11.20 Elekta
  • 10.20.1 Elekta Company Details
  • 10.20.2 Elekta Business Overview
  • 10.20.3 Elekta Interventional Oncology Introduction
  • 10.20.4 Elekta Revenue in Interventional Oncology Business (2015-2020)
  • 10.20.5 Elekta Recent Development
• 11.21 Galil Medical
  • 10.21.1 Galil Medical Company Details
  • 10.21.2 Galil Medical Business Overview
  • 10.21.3 Galil Medical Interventional Oncology Introduction
  • 10.21.4 Galil Medical Revenue in Interventional Oncology Business (2015-2020)
  • 10.21.5 Galil Medical Recent Development
• 11.22 Healthtronics
  • 10.22.1 Healthtronics Company Details
  • 10.22.2 Healthtronics Business Overview
  • 10.22.3 Healthtronics Interventional Oncology Introduction
  • 10.22.4 Healthtronics Revenue in Interventional Oncology Business (2015-2020)
  • 10.22.5 Healthtronics Recent Development
• 11.23 Insightec
  • 10.23.1 Insightec Company Details
  • 10.23.2 Insightec Business Overview
  • 10.23.3 Insightec Interventional Oncology Introduction
  • 10.23.4 Insightec Revenue in Interventional Oncology Business (2015-2020)
  • 10.23.5 Insightec Recent Development
• 11.24 Medwaves
  • 10.24.1 Medwaves Company Details
  • 10.24.2 Medwaves Business Overview
  • 10.24.3 Medwaves Interventional Oncology Introduction
  • 10.24.4 Medwaves Revenue in Interventional Oncology Business (2015-2020)
  • 10.24.5 Medwaves Recent Development
• 11.25 Mermaid Medical
  • 10.25.1 Mermaid Medical Company Details
  • 10.25.2 Mermaid Medical Business Overview
  • 10.25.3 Mermaid Medical Interventional Oncology Introduction
  • 10.25.4 Mermaid Medical Revenue in Interventional Oncology Business (2015-2020)
  • 10.25.5 Mermaid Medical Recent Development
• 11.26 Microsulis Medical
  • 10.26.1 Microsulis Medical Company Details
  • 10.26.2 Microsulis Medical Business Overview
  • 10.26.3 Microsulis Medical Interventional Oncology Introduction
  • 10.26.4 Microsulis Medical Revenue in Interventional Oncology Business (2015-2020)
  • 10.26.5 Microsulis Medical Recent Development
• 11.27 Monteris Medical
  • 10.27.1 Monteris Medical Company Details
  • 10.27.2 Monteris Medical Business Overview
  • 10.27.3 Monteris Medical Interventional Oncology Introduction
  • 10.27.4 Monteris Medical Revenue in Interventional Oncology Business (2015-2020)
  • 10.27.5 Monteris Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Interventional Oncology Scope and Market Size
Interventional Oncology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interventional Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Radiation Therapy
Ablation
Particle Embolization

Market segment by Application, split into
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer

Based on regional and country-level analysis, the Interventional Oncology market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Interventional Oncology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical